Skip to main content

The Science of Signaling

Dopamine & Norepinephrine: The Life of a Nerve Signal

Build it. Store it. Send it. Recover it. Discover the remarkable cycle behind two essential chemical messengers.

IFP Team17 min read
Begin reading
A labeled schematic shows a nerve ending releasing dopamine or norepinephrine, a receiving cell, and a return path through a reuptake transporter.

Follow one message​

If you arrived here from Glenn's video, this is the next step: slow the process down and follow one message from its building blocks to its return trip. Use the clickable diagram below to explore the route at your own pace.

How does a nerve cell turn a building block from food into a signal that helps you move, pay attention, or respond to the world? Two important messengers in that process are dopamine (DA) and norepinephrine (NE), also called noradrenaline (NA); dopamine helps regulate movement, motivation, and learning, while norepinephrine helps regulate alertness, attention, and parts of the body's automatic stress response. Goldstein and Eisenhofer, catecholamine physiology review

These chemicals belong to a family called catecholamines, and their effect depends on where they are released, which receptors receive them, and how the signal is brought to an end. Goldstein and Eisenhofer Think of this article as a guided tour: you do not need to memorize every chemical name to understand the story, and a full-name reference is waiting at the end.

Interactive physiology

Choose a messenger. Follow its journey.

Reduced motion is on. Explore every step using the buttons.

1 / 6 · Make

Make dopamine in the cytosol

Tyrosine hydroxylase (TH) converts tyrosine (Tyr) to L-3,4-dihydroxyphenylalanine (L-DOPA, or levodopa); aromatic L-amino acid decarboxylase (AADC) then makes dopamine (DA). Catecholamine physiology review

TH uses tetrahydrobiopterin (BH4), ferrous iron (Fe²⁺), and oxygen (O₂); AADC uses pyridoxal 5′-phosphate (PLP), active vitamin B6. Read the physiology

Before the nerve cell: phenylalanine → tyrosine, mainly in the liver.
Inside the sending nerve ending
CytosolTyr → L-DOPA → DATH, then AADC
VMAT2 loads the vesicle
Storage vesicleDopamineStored for release
Another possible routeMAO-A / MAO-BAt the outer mitochondrial membraneMetabolites
Cell membrane DAT · return door ↑
DA released intact↓
Reuptake
back to cytosol
Space outside the cell / synaptic cleft
Dopamine receptorsReceiving cell
COMT: a different cellular pathwayIn supporting brain cells and other tissues, not a free-floating cleft enzyme.

Schematic, not to scale. All chemical names and the full pathway are explained in the text below. Scientific basis for the diagram

Start with the map​

A synapse is a communication site between a nerve cell and another cell; the sending side is called presynaptic, the receiving side is postsynaptic, and the small space between them is the synaptic cleft. Basic Neurochemistry: storage and release Inside the sending nerve ending, the cytosol is the fluid where several chemical reactions happen, while vesicles are tiny membrane-wrapped storage packets. Basic Neurochemistry

Three types of worker keep the system organized: an enzyme changes a molecule, a transporter moves it across a membrane, and a receptor detects a signal and changes cell activity. Goldstein and Eisenhofer The drawings use one sending cell and one receiving cell to make the route clear, although dopamine and norepinephrine can also spread beyond a single synaptic cleft to influence nearby cells. Goldstein and Eisenhofer

From food to a nerve cell​

The story begins with phenylalanine (Phe), an amino acid supplied by dietary protein, and tyrosine (Tyr), which comes from food and from the body's conversion of phenylalanine. Phenylketonuria, Nature Reviews Disease Primers The enzyme phenylalanine hydroxylase (PAH) makes that conversion mainly in the liver and also in the kidneys, rather than carrying out the entire process inside every dopamine-producing nerve ending. Phenylketonuria review

PAH uses tetrahydrobiopterin (BH4), ferrous iron (Fe²⁺), and molecular oxygen (O₂) to turn phenylalanine into tyrosine. Phenylketonuria review BH4 is a chemical helper called a cofactor; it is not the name of a B vitamin. The catecholamine system in health and disease

To reach the brain, these amino acids must pass through the blood–brain barrier (BBB), the selective boundary between blood and brain tissue; large neutral amino acid transporter 1 (LAT1) helps carry them across that boundary. Phenylketonuria review Tyrosine must then enter a catecholamine-producing nerve cell, a separate transport step from crossing the barrier. Physiology, Noradrenergic Synapse

The important location change: phenylalanine becomes tyrosine mainly outside the brain; the nerve cell then uses tyrosine to begin making its own catecholamine messenger. Phenylketonuria review, The catecholamine system

Making dopamine​

Tyrosine becomes L-DOPA​

In the nerve cell's cytosol, tyrosine hydroxylase (TH) converts tyrosine into L-3,4-dihydroxyphenylalanine (L-DOPA), also called levodopa; this reaction uses BH4, ferrous iron, and oxygen. The catecholamine system TH is the pathway's rate-limiting enzyme, meaning this carefully regulated step helps set the pace of catecholamine production. Goldstein and Eisenhofer

L-DOPA becomes dopamine​

Next, aromatic L-amino acid decarboxylase (AADC), also known as DOPA decarboxylase (DDC), converts L-DOPA into dopamine. The catecholamine system Its helper is pyridoxal 5′-phosphate (PLP), an active form of vitamin B6. Goldstein and Eisenhofer

Dopamine moves into a storage packet​

Newly made dopamine is moved from the cytosol into a vesicle by vesicular monoamine transporter 2 (VMAT2). The ins and outs of vesicular monoamine transporters VMAT2 uses a difference in hydrogen ions, or protons (H⁺), across the vesicle membrane; a vesicular H⁺-adenosine triphosphatase (H⁺-ATPase) creates that difference using adenosine triphosphate (ATP), the cell's energy-carrying molecule. Vesicular monoamine transporters

In a dopaminergic neuron, dopamine is the messenger stored for release. Basic Neurochemistry Packaging separates the stored messenger from the cytosol and helps maintain a supply for future signals. Dopamine and vesicular monoamine transporter review

The norepinephrine branch​

A noradrenergic neuron follows the same early steps, but adds another reaction inside its vesicles: dopamine β-hydroxylase (DBH) converts dopamine into norepinephrine. Goldstein and Eisenhofer DBH uses copper, ascorbate (vitamin C), and oxygen, so the storage packet also serves as the site of this final conversion. Goldstein and Eisenhofer

This neuron makes its own dopamine intermediate before turning it into norepinephrine; dopamine does not have to leave a different neuron, cross a synapse, and enter this one first. Basic Neurochemistry The distinction is simple: dopamine is the finished messenger for one kind of nerve cell and a stepping stone to norepinephrine in another. The catecholamine system

Release and reception​

When an electrical impulse, called an action potential, reaches the nerve ending, voltage-gated calcium channels (VGCCs) open and allow calcium ions (Ca²⁺) to enter; calcium helps trigger vesicles to fuse with the cell membrane and release their contents through exocytosis. Basic Neurochemistry The cell releases intact dopamine or norepinephrine molecules, rather than breaking them down to get them into the synaptic space. Basic Neurochemistry

Released dopamine can bind dopamine receptors, while norepinephrine can bind alpha and beta adrenergic receptors; the receiving cell's response depends on the receptor and the surrounding circuit. Goldstein and Eisenhofer These messengers are therefore more than simple “pleasure” or “stress” chemicals, with effects that vary across brain and body systems. Goldstein and Eisenhofer

The sending cell also has feedback sensors called autoreceptors: D2 dopamine receptors and alpha-2 (α₂) adrenergic receptors can help reduce further release when the local signal is already strong. Dopamine transporter review, Noradrenergic Synapse Picture them as a built-in volume control, rather than an on/off switch.

Reuptake is not breakdown​

Much of the released messenger can be recovered through transporters on the sending cell's outer membrane: the dopamine transporter (DAT) and the norepinephrine transporter (NET). Goldstein and Eisenhofer These transporters use gradients of sodium (Na⁺) and chloride (Cl⁻) to bring messenger molecules back into the cell. Basic Neurochemistry

After reuptake, a molecule can be loaded back into a vesicle by VMAT2 and used again, or it can enter an intracellular breakdown pathway. Goldstein and Eisenhofer That is why reuptake is recovery, not chemical destruction: DAT and NET are return doors, while VMAT2 is the door into the storage packet. Dopamine transporter review

The names are helpful but not absolute rules: NET can also clear dopamine, especially in some brain regions where DAT is less abundant, such as the prefrontal cortex. Dopamine reuptake mechanisms review Diffusion and uptake by surrounding cells also contribute, so the return arrow in the diagram represents an important route, not the only possible destination. Goldstein and Eisenhofer

Two ways to change the molecule​

Recovery and reuse are only part of the story: enzymes also change catecholamines into other compounds called metabolites, and some of this processing happens continuously inside cells before any release occurs. Goldstein and Eisenhofer Two names are especially useful to understand.

SystemFull name and plain-language jobWhere and with what help?
MAO-A and MAO-BMonoamine oxidase A and monoamine oxidase B begin a reaction called oxidative deamination, which changes the amine-containing part of the molecule. MAO structure and mechanismOn the outer membrane of mitochondria inside cells; they use flavin adenine dinucleotide (FAD) and oxygen. MAO review
COMTCatechol-O-methyltransferase adds a small methyl group to the molecule's catechol ring. COMT biochemistry reviewPresent in several cell types and tissues; it uses S-adenosylmethionine (SAM or SAMe) as the methyl donor and magnesium (Mg²⁺). COMT review

MAO-A is especially important for norepinephrine metabolism in noradrenergic nerves, but both MAO-A and MAO-B can metabolize dopamine, with their contributions depending on the cell and tissue. Goldstein and Eisenhofer “A handles only norepinephrine; B handles only dopamine” is therefore not an accurate way to divide the work. MAO review

COMT has soluble and membrane-bound forms and is important in cells outside the releasing nerve ending, including supporting brain cells and other tissues. Goldstein and Eisenhofer MAO and COMT should not be pictured as three free-floating cleanup machines in the synaptic cleft; their location, access to the messenger, and order of action matter. Goldstein and Eisenhofer

When the system changes​

Physiology explains how a system works; pathophysiology explains what changes when normal function is disrupted. The comparison below highlights different points in the pathway, with arrows showing direction rather than measured concentrations or a personal diagnosis.

Interactive comparison

Where a change happens matters.

Usual pathwayFunctioning nerve cells synthesize messenger
Changed pathwayLoss of messenger-producing nerve cells

The supply network can change

In Parkinson’s disease, loss of dopamine-producing cells in the substantia nigra disrupts the circuits that coordinate movement. NINDS: Parkinson’s disease

This is a specific neurological disease, not a diagnosis made from a general feeling of low motivation.

Real conditions show why the location of a problem matters: in Parkinson's disease, loss of dopamine-producing neurons in the substantia nigra disrupts movement circuits, contributing to slowed movement and other motor symptoms. National Institute of Neurological Disorders and Stroke: Parkinson's disease That is different from DBH deficiency, a rare disorder in which impaired conversion of dopamine to norepinephrine can cause severe blood-pressure drops on standing. MedlinePlus: DBH deficiency

An earlier problem can occur in phenylketonuria (PKU), where impaired PAH activity allows phenylalanine to accumulate and alters the supply of other large neutral amino acids to the brain. Phenylketonuria review These are specific disease mechanisms, not labels to assign from everyday changes in mood, attention, or energy; diagnosis requires a clinical evaluation.

The breakdown pathways​

You can understand the signal without memorizing these routes. For readers who want the chemical detail, the following are important examples rather than a map of every possible reaction.

Dopamine: one route toward HVA​

Dopamine → DOPAL → DOPAC → HVA is a major route involving MAO, then aldehyde dehydrogenase, then COMT. Goldstein and Eisenhofer

  • DOPAL: 3,4-dihydroxyphenylacetaldehyde, an aldehyde intermediate formed through MAO action. Goldstein and Eisenhofer
  • DOPAC: 3,4-dihydroxyphenylacetic acid, produced when aldehyde dehydrogenase (ALDH) processes DOPAL using nicotinamide adenine dinucleotide, oxidized form (NAD⁺). Goldstein and Eisenhofer
  • HVA: homovanillic acid, produced when COMT acts on DOPAC. Goldstein and Eisenhofer

COMT can also act first, converting dopamine to 3-methoxytyramine (3-MT), which can then be processed through MAO and ALDH reactions toward HVA. Goldstein and Eisenhofer There is not one compulsory order in which every molecule meets these enzymes. Goldstein and Eisenhofer

Norepinephrine: several steps, several locations​

One important route is norepinephrine → DOPEGAL → DHPG → MHPG, involving MAO, aldehyde reductase, and COMT. Goldstein and Eisenhofer

  • DOPEGAL: 3,4-dihydroxyphenylglycolaldehyde, the aldehyde formed through MAO action on norepinephrine. Goldstein and Eisenhofer
  • DHPG: 3,4-dihydroxyphenylglycol, made by aldehyde reductase (AR) with reduced nicotinamide adenine dinucleotide phosphate (NADPH). Goldstein and Eisenhofer
  • MHPG: 3-methoxy-4-hydroxyphenylglycol, produced when COMT acts on DHPG. Goldstein and Eisenhofer

Further processing, especially in the liver, can turn MHPG into vanillylmandelic acid (VMA) through alcohol dehydrogenase (ADH) and ALDH reactions; ADH uses NAD⁺ and zinc. Goldstein and Eisenhofer An alternative branch begins when COMT converts norepinephrine into normetanephrine (NMN), before further metabolism. Goldstein and Eisenhofer

These pathways extend across cells and tissues, not just across the tiny gap of one synapse. Goldstein and Eisenhofer The useful takeaway is that reuptake, repackaging, and chemical breakdown are different jobs that work together.

Your plain-language reference​

Use this section as a lookup rather than a memorization list. It covers the abbreviated names used in the article and graphics; ions, energy sources, and reaction ingredients are separated from enzymes because they are not all “cofactors.”

Messengers, building blocks, and metabolites​

Short formFull nameRole in this article
PhePhenylalanineDietary amino acid that can become tyrosine. PAH review
TyrTyrosineStarting amino acid for catecholamine synthesis in the nerve cell. Catecholamine review
L-DOPAL-3,4-dihydroxyphenylalanine; levodopaIntermediate between tyrosine and dopamine. Catecholamine review
DADopamineMessenger and precursor to norepinephrine. Physiology review
NE / NANorepinephrine / noradrenalineTwo names for the same messenger. Physiology review
DOPAL3,4-DihydroxyphenylacetaldehydeDopamine-derived aldehyde intermediate. Metabolism review
DOPAC3,4-Dihydroxyphenylacetic acidDopamine metabolite made from DOPAL. Metabolism review
3-MT3-MethoxytyramineProduct of COMT acting on dopamine. Metabolism review
HVAHomovanillic acidDownstream dopamine metabolite. Metabolism review
DOPEGAL3,4-DihydroxyphenylglycolaldehydeNorepinephrine-derived aldehyde intermediate. Metabolism review
DHPG3,4-DihydroxyphenylglycolProduct of AR acting on DOPEGAL. Metabolism review
MHPG3-Methoxy-4-hydroxyphenylglycolProduct of COMT acting on DHPG. Metabolism review
NMNNormetanephrineNorepinephrine metabolite; here NMN does not mean the supplement nicotinamide mononucleotide. Metabolism review
VMAVanillylmandelic acidDownstream metabolite of norepinephrine and epinephrine; epinephrine is also called adrenaline. Metabolism review

Enzymes, transporters, and receptors​

Short formFull namePlain-language job
PAHPhenylalanine hydroxylaseConverts phenylalanine to tyrosine. PAH review
THTyrosine hydroxylaseConverts tyrosine to L-DOPA. Catecholamine review
AADC / DDCAromatic L-amino acid decarboxylase / DOPA decarboxylaseTwo names for the enzyme converting L-DOPA to dopamine. Catecholamine review
DBHDopamine β-hydroxylaseConverts dopamine to norepinephrine inside vesicles. Physiology review
MAO-A / MAO-BMonoamine oxidase A / monoamine oxidase BRelated enzymes involved in monoamine metabolism. MAO review
COMTCatechol-O-methyltransferaseAdds a methyl group to a catechol molecule. COMT review
ALDHAldehyde dehydrogenaseConverts aldehydes into acids. Metabolism review
ARAldehyde reductaseConverts an aldehyde into an alcohol, including DOPEGAL to DHPG. Metabolism review
ADHAlcohol dehydrogenaseHelps process MHPG on the route to VMA. Metabolism review
LAT1Large neutral amino acid transporter 1Carries large neutral amino acids across the blood–brain barrier. PAH review
VMAT2Vesicular monoamine transporter 2Loads monoamines into nerve-cell vesicles. VMAT review
DAT / NETDopamine transporter / norepinephrine transporterRecover released messengers across the cell membrane. Transporter review, Physiology review
H⁺-ATPaseH⁺-adenosine triphosphatase; vesicular proton pumpUses ATP to build the vesicle's proton gradient. VMAT review
VGCCVoltage-gated calcium channelOpens with electrical activity, allowing calcium entry. Basic Neurochemistry
D2 / α₂D2 dopamine receptor / alpha-2 adrenergic receptorReceptor types that can serve as release-limiting autoreceptors. Transporter review, Noradrenergic Synapse

Chemical helpers, ions, and energy sources​

Short form or nameFull nameWhere it fits
BH4TetrahydrobiopterinCofactor for PAH and TH. Catecholamine review
PLPPyridoxal 5′-phosphateActive vitamin B6 cofactor for AADC. Catecholamine review
FADFlavin adenine dinucleotideCofactor used by MAO. MAO review
SAM / SAMeS-adenosylmethionineMethyl donor for COMT; after donation it becomes S-adenosylhomocysteine (SAH). COMT review
SAHS-adenosylhomocysteineProduct remaining after SAM donates its methyl group. COMT review
NAD⁺Nicotinamide adenine dinucleotide, oxidized formCoenzyme used in ALDH and ADH reactions. Metabolism review
NADPHReduced nicotinamide adenine dinucleotide phosphateSupplies reducing power for AR. Metabolism review
ATPAdenosine triphosphateEnergy source for the vesicle's proton pump. VMAT review
Fe²⁺Ferrous ironHelps PAH and TH function. Catecholamine review
Cu; ascorbateCopper; vitamin CHelpers used by DBH. Metabolism review
Mg²⁺; Zn²⁺Magnesium ion; zinc ionMagnesium supports COMT; zinc supports ADH. COMT review, Metabolism review
O₂Molecular oxygenReaction ingredient for PAH, TH, DBH, and MAO. Catecholamine review, MAO review
H⁺; Ca²⁺Hydrogen ion/proton; calcium ionProton gradient supports vesicle loading; calcium entry triggers release. VMAT review, Basic Neurochemistry
Na⁺; Cl⁻Sodium ion; chloride ionGradients help power reuptake transporters. Basic Neurochemistry

BBB means blood–brain barrier, and PKU means phenylketonuria. Phenylketonuria review The helpers above explain normal chemistry; their presence in a pathway does not establish a need for an individual supplement or a reason to change treatment.

The idea to remember​

Build. Store. Release. Receive. Recover. Reuse or metabolize. That sequence connects the pathway, while different transporters and enzymes control different steps. Goldstein and Eisenhofer Healthy signaling depends on this coordination, not simply on making as much dopamine or norepinephrine as possible. Goldstein and Eisenhofer

Coming in future editions​

This foundation will support a closer look at how genes and medications influence chemical signaling. Planned topics include:

  • Genetic testing and interpretation: catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) gene variants, what results can tell us, and the limits of using them to guide care.
  • Antidepressant pharmacology: selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs), with a clear distinction between serotonin pathways and the dopamine/norepinephrine pathways introduced here.
  • Dopamine-modulating medicines: where different medicines act along a signaling pathway, and why their effects cannot be reduced to simply “more” or “less” dopamine.
  • Stimulants and related substances: the mechanisms and risks of cocaine, amphetamines, and 3,4-methylenedioxymethamphetamine (MDMA), explained as education rather than instructions for use.

Each edition will separate the underlying mechanism from the evidence for clinical decisions. The goal is to make informed conversations with licensed medical providers easier, not to turn a single genetic result into a diagnosis or treatment plan.

Bring the science into context​

Bring questions about persistent changes in attention, movement, mood, or energy to licensed medical providers. An individualized conversation can place symptoms, medications, nutrition, and relevant testing in context without reducing your health to one molecule.

Visit IFP.life to learn about becoming a patient. This article is educational and does not diagnose a condition or recommend starting, stopping, or adjusting a medication or supplement.

Explore all articles